[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT84704B - Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem

Info

Publication number
PT84704B
PT84704B PT84704A PT8470487A PT84704B PT 84704 B PT84704 B PT 84704B PT 84704 A PT84704 A PT 84704A PT 8470487 A PT8470487 A PT 8470487A PT 84704 B PT84704 B PT 84704B
Authority
PT
Portugal
Prior art keywords
tiolactam
derivatives
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT84704A
Other languages
English (en)
Other versions
PT84704A (en
Inventor
Hitoshi Ikeda
Kanji Meguro
Yujiro Yamamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PT84704A publication Critical patent/PT84704A/pt
Publication of PT84704B publication Critical patent/PT84704B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT84704A 1986-04-17 1987-04-16 Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem PT84704B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8929586 1986-04-17
JP14594186 1986-06-20

Publications (2)

Publication Number Publication Date
PT84704A PT84704A (en) 1987-05-01
PT84704B true PT84704B (pt) 1989-11-30

Family

ID=26430721

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84704A PT84704B (pt) 1986-04-17 1987-04-16 Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem

Country Status (19)

Country Link
US (1) US4771050A (pt)
EP (1) EP0243018B1 (pt)
JP (1) JPS63107970A (pt)
KR (1) KR870010024A (pt)
CN (1) CN1020098C (pt)
AR (1) AR244674A1 (pt)
AU (1) AU602641B2 (pt)
CA (1) CA1287629C (pt)
DE (1) DE3765682D1 (pt)
DK (1) DK184587A (pt)
ES (1) ES2022889B3 (pt)
FI (1) FI89711C (pt)
GR (1) GR3001210T3 (pt)
HK (1) HK108293A (pt)
HU (1) HU198699B (pt)
IE (1) IE60246B1 (pt)
NO (1) NO167916C (pt)
PT (1) PT84704B (pt)
SU (1) SU1538895A3 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2996475B2 (ja) * 1989-12-22 1999-12-27 サントリー株式会社 ベンズオキサジノン誘導体及びそれを有効成分として含有する除草剤
TW200402B (pt) * 1990-08-13 1993-02-21 Senju Pharma Co
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
IE914455A1 (en) * 1990-12-27 1992-07-01 Green Cross Corp 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
DE69329618T2 (de) * 1992-08-31 2001-05-17 Santen Pharmaceutical Co., Ltd 3-oxo-1,4-benzothiazin-derivate
JP3126541B2 (ja) * 1993-03-26 2001-01-22 千寿製薬株式会社 ベンゾチアゾール誘導体、その製法及びその用途
WO1995013269A1 (fr) * 1993-11-12 1995-05-18 Santen Pharmaceutical Co., Ltd. Derive de 1,4-benzothiazine
CN100378118C (zh) * 1997-04-15 2008-04-02 Csir公司 具有食欲抑制剂活性的药物组合物
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
US6713477B1 (en) 2000-04-19 2004-03-30 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivatives
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
WO2005082872A1 (ja) * 2004-03-02 2005-09-09 Dainippon Sumitomo Pharma Co., Ltd. ベンゾチアジン－３－オン化合物及びその製造中間体
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
EP2368560A1 (en) 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos
EP2848252A3 (en) 2007-03-23 2015-06-17 The Board of Regents of the University of Texas System Aldose reductase inhibitors for use in treating uveitis
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
AU2011348074B2 (en) 2010-12-23 2016-04-28 The Board Of Regents Of The University Of Texas System Methods for treating COPD
WO2019165195A1 (en) 2018-02-22 2019-08-29 Srivastava Satish Combination therapy for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
US3923709A (en) * 1974-08-30 1975-12-02 Monsanto Co 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors

Also Published As

Publication number Publication date
NO871526L (no) 1987-10-19
EP0243018B1 (en) 1990-10-24
IE60246B1 (en) 1994-06-15
HUT45515A (en) 1988-07-28
AU602641B2 (en) 1990-10-18
ES2022889B3 (es) 1991-12-16
HU198699B (en) 1989-11-28
JPS63107970A (ja) 1988-05-12
KR870010024A (ko) 1987-11-30
NO871526D0 (no) 1987-04-10
CN1020098C (zh) 1993-03-17
EP0243018A1 (en) 1987-10-28
NO167916C (no) 1991-12-27
GR3001210T3 (en) 1992-07-30
FI89711B (fi) 1993-07-30
HK108293A (en) 1993-10-22
US4771050A (en) 1988-09-13
JPH034550B2 (pt) 1991-01-23
CN87102891A (zh) 1987-11-04
FI871719A (fi) 1987-10-18
IE871012L (en) 1987-10-17
FI89711C (fi) 1993-11-10
DK184587D0 (da) 1987-04-10
NO167916B (no) 1991-09-16
DK184587A (da) 1987-10-18
FI871719A0 (fi) 1987-04-16
CA1287629C (en) 1991-08-13
AR244674A1 (es) 1993-11-30
SU1538895A3 (ru) 1990-01-23
AU7073087A (en) 1987-10-22
PT84704A (en) 1987-05-01
DE3765682D1 (de) 1990-11-29

Similar Documents

Publication Publication Date Title
PT82591B (pt) Processo para a preparacao de derivados do acido ascorbico e de composicoes farmaceuticas que os contem
PT84698B (pt) Processo para a preparacao de derivados de acido acrilico e de composicoes fungicidas que os contem
PT82941B (pt) Processo para a preparacao de esteres do acido hialuronico e de composicoes farmaceuticas que os contem
PT93089A (pt) Processo para a preparacao de derivados do acido propenoico e de composicoes fungicidas que os contem
PT84277B (pt) Processo para a preparacao de derivados de indolizina e de composicoes que os contem
PT84053B (pt) Processo para a preparacao de derivados do acido n-azabiciclo-indol-carboxilico-(1) substituido e de composicoes farmaceuticas contendo-os
PT91287A (pt) Processo de preparacao de derivados do acido indazol-3-carboxilico e de composicoes farmaceuticas que os contem
PT84704B (pt) Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT80363B (pt) Processo para a preparacao de derivados de fenol e de composicoes farmaceuticas que os contem
PT84187B (pt) Processo para a preparacao de novos derivados da isoquinolina e de composicoes farmaceuticas que os contem
PT84364B (pt) Processo para a preparacao de derivados do acido 1h-imidazol-5-carboxilico e de composicoes herbicidas que os contem
PT84462B (pt) Rocesso para a preparacao de novos tiazois e oxazois substituidos e de composicoes farmaceuticas que os contem
PT81502B (pt) Processo para a preparacao de derivados de colecalciferol e de composicoes farmaceuticas que os contem
PT83604B (pt) Processo para a preparacao de derivados da flavona e de composicoes farmaceuticas que os contem
PT88335A (pt) Processo para a preparacao de derivados do acido 1,4-dihidro-4-oxo-3-quinolinocarboxilico e de composicoes farmaceuticas que os contem
PT82901B (pt) Processo para a preparacao de derivados do acido antranilico dotados de accao terapeutica e de composicoes farmaceuticas que os contem
PT89145A (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
PT88351A (pt) Processo para a preparacao de derivados de isoxazol-beta-carbolina e de composicoes farmaceuticas que os contem
PT84123B (pt) Processo para a preparacao de derivados substituidos do acido 4-amibo-3-hidroxibutirico e de composicoes farmaceuticas que os contem
PT83565B (pt) Processo para a preparacao de derivados do acido aril-heterociclil-alcoxi-acetico e de composicoes farmaceuticas que os contem
PT90904A (pt) Processo para a preparacao de derivados de 3-oxo-propanonitrilo triciclicos e de composicoes farmaceuticas que os contem
PT82440B (pt) Processo para a preparacao de eteres ciclopentilicos e de composicoes farmaceuticas que os contem
PT84428B (pt) Processo para a preparacao de derivados de acidos 1-metil-1h-imidazol-5- -carboxilicos e de composicoes herbicidas que os contem

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19981130